Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
All cancer types, Cancer spread to the bone, Cancer spread to the brain, Cancer spread to the liver, Cancer spread to the lung, Secondary cancers
Closed
Phase 1
This is a trial of lurbinectedin (PM01183) to treat advanced solid tumours. It is open to people with all types of cancers that have spread to another part of the body (advanced) apart from leukaemia, lymphoma and myeloma.
Recruitment start: 5 August 2014
Recruitment end: 13 April 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Martin Forster
Experimental Cancer Medicine Centre (ECMC)
Pharma Mar
Last reviewed: 22 Jun 2016
CRUK internal database number: 12801
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
